What is the long term acid inhibitor treatment in gastroesophageal reflux disease? What are the potential problems related to long term acid inhibitor treatment in gastroesophageal reflux disease? How should these cases be followed?
Abstract The meta-analyses of observational studies (OBS) showed the risk of any fracture and hip fracture slightly increased with proton pump inhibitor (PPI) treatment depending on the dose and regardless of time. This was not observed with histamine-2 receptor antagonists (H2RA). The risk of bacte...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Turkish Society of Gastroenterology
2017-01-01
|
| シリーズ: | The Turkish Journal of Gastroenterology |
| 主題: | |
| オンライン･アクセス: | https://turkjgastroenterol.org/index.php/tjg/article/view/3010 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|